No insider purchase over the last 90 days. The latest, by Goodeve H Philip, was filed 06 Apr 2017.
This page follows insider dealings at MetaStat, Inc. as filed with SEC (Form 4). MetaStat, Inc. has had no insider filing for more than a year; the last one goes back to 6 April 2017.
Over the whole record (from 2009), the tally stands at 23 purchases and 6 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 44 declarations
MetaStat, Inc. is a company focused on developing diagnostic solutions for cancer. It aims to improve patient outcomes through innovative technologies.